Low Molecular Weight Heparin in Obstetrics

Sushil Chawla

doi:10.5005/jogyp-11012-0015

SEARCH WITHIN CONTENT

Online First

Low Molecular Weight Heparin in Obstetrics

Sushil Chawla

Keywords : Abruptio placentae, Antiphospholipid syndrome, Fetal growth restriction, Heparin, Intrauterine fetal death, Low molecular weight heparin, Preeclampsia, Recurrent pregnancy loss, Thrombophilias

Citation Information : Chawla S. Low Molecular Weight Heparin in Obstetrics. J Obstet Gynaecol 2023; 1 (2):31-32.

DOI: 10.5005/jogyp-11012-0015

License: CC BY-NC 4.0

Published Online: 24-11-2023

ARTICLE
REFERENCES

Abstract

HTML PDF Share

Hemker HC. A century of heparin: Past, present and future. J Thromb Haemost 2016;14(12):2329–2338. DOI: 10.1111/jth.13555.
Heestermans M, Poenou G, Hamzeh–Cognasse H, et al. Anticoagulants: A short history, their mechanism of action, pharmacology, and indications. Cells 2022;11(20):3214. DOI: 10.3390/cells11203214.
Greer I, Hunt BJ. Low molecular weight heparin in pregnancy: Current issues. British J Haematol 2005;128(5):593–601. DOI: 10.1111/j.1365-2141.2004.05304.x.
Middleton P, Shepherd E, Gomersall JC. Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period. Cochrane Database Syst Rev 2021;3(3):CD001689. DOI: 10.1002/14651858.CD001689.pub4.
D'Ippolito S, Ortiz AS, Veglia M, et al. Low molecular weight heparin in obstetric care: A review of the literature. Reprod Sci 2011;18(7): 602–613. DOI: 10.1177/1933719111404612.

PDF Share